Literature DB >> 29460170

[Epidemiology and diagnostic assessment of small renal masses].

B K Ziegelmüller1, A Spek2, B Szabados2, J Casuscelli2, D-A Clevert2, M Staehler2.   

Abstract

BACKGROUND: The incidence of small renal masses has been rising over the last few decades. At the same time, mortality of renal cell carcinoma (RCC) is decreasing. These trends can be explained by the availability of improved therapeutic measures and the good prognosis of small renal masses (SRM) turning out to be histopathologically benign or of low malignancy in many cases.
OBJECTIVES: The aim of this article is to present epidemiology and diagnostic assessment of SRM.
MATERIALS AND METHODS: Statistics, basic research, guidelines.
RESULTS: The incidence of SRM is rising due to the widespread use of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and contrast-enhanced ultrasound (CEUS). Sensitivity is excellent for CEUS and for CECT in the characterization of SRM, while good specificity values can be reached by MRI. For characterization of complex cystic renal masses, CEUS has good diagnostic accuracy.
CONCLUSIONS: Due to improved diagnostic possibilities, SRMs can be diagnosed in early asymptomatic stages. As SRM have a good prognosis and often are of low malignancy therapy, options should be carefully considered; especially in older patients, active surveillance should considered.

Entities:  

Keywords:  Active surveillance; Computed tomography; Magnetic resonance imaging; Renal cell carcinoma; Ultrasound, contrast-enhanced

Mesh:

Substances:

Year:  2018        PMID: 29460170     DOI: 10.1007/s00120-018-0585-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

1.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

Review 2.  Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT.

Authors:  S Sheth; J C Scatarige; K M Horton; F M Corl; E K Fishman
Journal:  Radiographics       Date:  2001-10       Impact factor: 5.333

Review 3.  International variations and trends in renal cell carcinoma incidence and mortality.

Authors:  Ariana Znaor; Joannie Lortet-Tieulent; Mathieu Laversanne; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2014-10-16       Impact factor: 20.096

Review 4.  Rationale for percutaneous biopsy and histologic characterisation of renal tumours.

Authors:  Alessandro Volpe; Antonio Finelli; Inderbir S Gill; Michael A S Jewett; Guido Martignoni; Thomas J Polascik; Mesut Remzi; Robert G Uzzo
Journal:  Eur Urol       Date:  2012-05-12       Impact factor: 20.096

5.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

6.  Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis.

Authors:  Masanori Kato; Takashi Suzuki; Yasuyoshi Suzuki; Yoshio Terasawa; Hironobu Sasano; Yoichi Arai
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

7.  The diagnostic value of contrast-enhanced ultrasound in differentiating small renal carcinoma and angiomyolipoma.

Authors:  Lin Chen; Ling Wang; Xuehong Diao; Weiqing Qian; Liang Fang; Yun Pang; Jia Zhan; Yue Chen
Journal:  Biosci Trends       Date:  2015-08-11       Impact factor: 2.400

8.  Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.

Authors:  See Hyung Kim; Chan Sun Kim; Mi Jeong Kim; Jeong Yeon Cho; Seung Hyun Cho
Journal:  AJR Am J Roentgenol       Date:  2016-01       Impact factor: 3.959

9.  The changing pattern of kidney cancer incidence and mortality in Europe.

Authors:  Fabio Levi; Jacques Ferlay; Carlotta Galeone; Franca Lucchini; Eva Negri; Peter Boyle; Carlo La Vecchia
Journal:  BJU Int       Date:  2008-01-30       Impact factor: 5.588

10.  Pathological nature of renal tumors - does size matter?

Authors:  Lutfi Ali S Kurban; Alireza Vosough; Preman Jacob; Deepak Prasad; Thomas Lam; Neil Scott; Bhaskar K Somani
Journal:  Urol Ann       Date:  2017 Oct-Dec
View more
  7 in total

1.  [Small renal cell carcinoma-active surveillance and ablation].

Authors:  J J Wendler; R Damm; U-B Liehr; T Brunner; M Pech; M Schostak
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

2.  A Systematic Review and Meta-Analysis of Comparison of Outcomes of Robot-Assisted versus Open Partial Nephrectomy in Clinical T1 Renal Cell Carcinoma Patients.

Authors:  Yixiu Ni; Xiaohua Yang
Journal:  Urol Int       Date:  2022-02-22       Impact factor: 1.934

3.  Neutrophil-lymphocyte ratio as a prognostic factor for minute clear cell renal cell carcinoma diagnosed using multi-slice spiral CT.

Authors:  Li Chen; Lingjun Qi; Jing Zhang; Qian Ma; Xiaoxin Chai
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.889

4.  The independent indicators for differentiating renal cell carcinoma from renal angiomyolipoma by contrast-enhanced ultrasound.

Authors:  Hongli Cao; Liang Fang; Lin Chen; Jia Zhan; Xuehong Diao; Yingchun Liu; Chen Lu; Zhengwang Zhang; Yue Chen
Journal:  BMC Med Imaging       Date:  2020-03-30       Impact factor: 1.930

5.  Association of Hypertension and Blood Pressure With Kidney Cancer Risk: A Nationwide Population-Based Cohort Study.

Authors:  Chang Seong Kim; Kyung-Do Han; Hong Sang Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

Review 6.  Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic.

Authors:  Stênio de Cássio Zequi; Diego Abreu
Journal:  Int Braz J Urol       Date:  2020-07       Impact factor: 1.541

7.  Comparison of the Results of Therapy for cT1 Renal Carcinoma with Nephron-Sparing Surgery (NSS) vs. Percutaneous Thermal Ablation (TA).

Authors:  Michał Rusinek; Marek Salagierski; Waldemar Różański; Bartłomiej Jakóbczyk; Michał Markowski; Marek Lipiński; Jacek Wilkosz
Journal:  J Pers Med       Date:  2022-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.